Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KALOW W")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 120

  • Page / 5
Export

Selection :

  • and

PHARMACOGENETICS OF DRUGS USED IN ANAESTHESIA = PHARMACOGENETIQUE DES PRODUITS UTILISES EN ANESTHESIEKALOW W.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 415-427; BIBL. 3P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

THE METABOLISM OF XENOBIOTICS IN DIFFERENT POPULATIONSKALOW W.1982; CAN. J. PHYSIOL. PHARMACOL.; ISSN 0008-4212; CAN; DA. 1982; VOL. 60; NO 1; PP. 1-12; ABS. FRE; BIBL. 3 P.Article

The genetic defect of mephenytoin hydroxylationKALOW, W.Xenobiotica (London. Print). 1986, Vol 16, Num 5, pp 379-389, issn 0049-8254Article

ACUTE AND LATENT LEUKOPENIC REACTION TO ANTIPYRINEKADAR D; KALOW W.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 6; PP. 820-822; BIBL. 2 REF.Article

GENETIC FACTORS IN HEPATIC DRUG OXIDATIONSKALOW W; INABA T.1976; PROGR. LIVER DIS.; U.S.A.; DA. 1976; VOL. 5; PP. 246-258; BIBL. 3 P.Article

Pharmacogenetics : its biologic roots and the medical challengeKALOW, W.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 3, pp 235-241, issn 0009-9236Article

The Pennsylvania State University College of Medicine, 1990 Bernard B. Brodie lecture. Pharmacogenetics : past and futureKALOW, W.Life sciences (1973). 1990, Vol 47, Num 16, pp 1385-1397, issn 0024-3205, 13 p.Article

Genetic variation in the human hepatic cytochrome P-450 systemKALOW, W.European journal of clinical pharmacology. 1987, Vol 31, Num 6, pp 633-641, issn 0031-6970Article

Variability of caffeine metabolism in humansKALOW, W.Arzneimittel-Forschung. 1985, Vol 35, Num 1A, pp 319-324, issn 0004-4172Article

Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicatorsKALOW, W.Pharmacogenomics journal (Print). 2002, Vol 2, Num 1, pp 12-14, issn 1470-269XArticle

SALIVARY EXCRETION OF AMOBARBITAL IN MAN.INABA T; KALOW W.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 558-562; BIBL. 13 REF.Article

INHIBITION OF SPARTEINE OXIDATION IN HUMAN LIVER BY TRICYCLIC ANTIDEPRESSANTS AND OTHER DRUGSOTTON SV; INABA T; KALOW W et al.1983; LIFE SCIENCES(1973; ISSN 0024-3205; GBR; DA. 1983; VOL. 32; NO 7; PP. 795-800; BIBL. 20 REF.Article

METABOLISM OF COCAINE IN MAN.INABA T; STEWART DJ; KALOW W et al.1978; CLIN. PHARMACOL. THERAP.; U.S.A.; DA. 1978; VOL. 23; NO 5; PP. 547-552; BIBL. 20 REF.Article

THE CAFFEINE TEST OF ISOLATED HUMAN MUSCLE IN RELATION TO MALIGNANT HYPERTHERMIA.KALOW W; BRITT BA; RICHTER A et al.1977; CANAD. ANAESTHETISTS' SOC. J.; CANADA; DA. 1977; VOL. 24; NO 6; PP. 678-694; ABS. FR.; BIBL. 1 P. 1/2Article

COMPARATIVE DRUG ELIMINATION IN MAN-DIPHENYLHYDANTOIN AND AMOBARBITAL.BRIEN JF; INABA T; KALOW W et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 9; NO 1; PP. 79-83; BIBL. 15 REF.Article

HUMAN METABOLISM OF ANTIPYRINE LABELLED WITH 14C IN THE PYRAZOLONE RING OR IN THE N-METHYL GROUPUCHINO H; INABA T; KALOW W et al.1983; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1983; VOL. 13; NO 3; PP. 155-162; BIBL. 22 REF.Article

THE FATE OF ORALLY ADMINISTERED (4-14C) PHENYTOIN IN TWO HEALTHY MALE VOLUNTEERSKADAR D; FECYCZ TD; KALOW W et al.1983; CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY; ISSN 0008-4212; CAN; DA. 1983; VOL. 61; NO 4; PP. 403-407; ABS. FRE; BIBL. 19 REF.Article

AMOBARBITAL METABOLISM IN MAN. DETERMINATION OF N-HYDROXYAMOBARBITAL AND 3'-HYDROXYAMOBARBITAL IN URINE BY GAS CHROMATOGRAPHY CHEMICAL IONIZATION MASS SPECTROMETRY.TANG BK; INABA T; KALOW W et al.1977; BIOMED. MASS SPECTROM.; G.B.; DA. 1977; VOL. 4; NO 2; PP. 73-76; BIBL. 7 REF.Article

DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINEINABA T; OTTON SV; KALOW W et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 4; PP. 547-549; BIBL. 12 REF.Article

N-HYDROXYLATION OF PENTOBARBITAL IN MAN.TANG BK; INABA T; KALOW W et al.1977; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1977; VOL. 5; NO 1; PP. 71-74; BIBL. 6 REF.Article

METABOLIC FATE OF PHENOBARBITAL IN MAN: N-GLUCOSIDE FORMATIONTANG BK; KALOW W; GREY AA et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 5; PP. 315-318; BIBL. 16 REF.Article

N-DEMETHYLATION OF COCAINE IN THE RAT AND IN ISOLATED RAT HEPATOCYTES: COMPARISON WITH AMINOPYRINE DEMETHYLATIONSTEWART DJ; INABA T; KALOW W et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 207; NO 1; PP. 171-177; BIBL. 20 REF.Article

AMOBARBITAL METABOLISM IN MAN: N-GLUCOSIDE FORMATIONTANG BK; KALOW W; GREY AA et al.1978; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1978; VOL. 21; NO 1; PP. 45-53; BIBL. 14 REF.Article

ISOLATION AND IDENTIFICATION OF 5-ACETYLAMINO-6-FORMYLAMINO-3-METHYLURACIL AS A MAJOR METABOLITE OF CAFFEINE IN MANTANG BK; GRANT DM; KALOW W et al.1983; DRUG METABOLISM AND DISPOSITION; ISSN 0090-9556; USA; DA. 1983; VOL. 11; NO 3; PP. 218-220; BIBL. 14 REF.Article

POLYMORPHIC N-ACETYLATION OF A CAFFEINE METABOLITEGRANT DM; TANG BK; KALOW W et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 355-359; BIBL. 30 REF.Article

  • Page / 5